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In metazoans, tissues experiencing proteotoxic
stress induce ‘‘transcellular chaperone signaling’’
(TCS) that activates molecular chaperones, such as
hsp-90, in distal tissues. How this form of inter-tissue
communication is mediated to upregulate systemic
chaperone expression and whether it can be utilized
to protect against protein misfolding diseases
remain open questions. Using C. elegans, we identi-
fied key components of a systemic stress signaling
pathway that links the innate immune response
with proteostasis maintenance. We show that mild
perturbation of proteostasis in the neurons or the
intestine activates TCS via the GATA zinc-finger tran-
scription factor PQM-1. PQM-1 coordinates neuron-
activated TCS via the innate immunity-associated
transmembrane protein CLEC-41, whereas intes-
tine-activated TCS depends on the aspartic protease
ASP-12. Both TCS pathways can induce hsp-90 in
muscle cells and facilitate amelioration of Ab3-42-
associated toxicity. This may have powerful implica-
tions for the treatment of diseases related to proteo-
stasis dysfunction.
INTRODUCTION
All living systems are confronted with a broad range of environ-
mental insults and physiological changes that can result in
cellular stress and macromolecular damage (Morimoto et al.,
1997). To re-establish protein homeostasis or proteostasis,
each cell has the ability to rapidly activate stress response path-
ways. These include the heat shock factor-1 (HSF-1)-mediated
heat shock response (HSR), the unfolded protein response
(UPR), and the insulin-like-signaling pathway (ILS) mediated by
the FOXO/DAF-16 transcription factor (Gardner et al., 2013;
Hsu et al., 2003; Morimoto et al., 1997). Stress response path-
ways upregulate cell-autonomous modifiers of the proteostasis
network (PN), such as molecular chaperones, that protect pro-
tein conformation during stress, refold misfolded proteins, andCell
This is an open access article undtarget irreversibly misfolded proteins to the degradation machin-
ery (Akerfelt et al., 2010; Morimoto et al., 1997).
In addition to stress response cues that act locally and within
the cell, multicellular organisms also require intercellular stress
response pathways that allow for coordinated activation of pro-
tective PN components across tissues to preserve proteostasis
in the entire organism. In C. elegans, this is achieved by activa-
tion of the HSR via the thermo-sensory neuronal circuitry in
response to heat stress (Prahlad et al., 2008). In response to
stressors of intracellular origin, such as perturbed mitochondrial
function, DNA damage, and altered chaperone expression in
specific tissues, a systemic stress signaling response is acti-
vated that promotes PN components in cells distinct from the
stressed sender cell (Chikka et al., 2016; Durieux et al., 2011;
Ermolaeva et al., 2013; van Oosten-Hawle and Morimoto,
2014; Prahlad and Morimoto, 2011; Taylor et al, 2014; Taylor
and Dillin, 2013). Transcellular regulation of protective stress re-
sponses is not unique to the metazoan system of C. elegans
and has been observed in other model systems, including ver-
tebrates (Mahadevan et al., 2011; Owusu-Ansah et al., 2013;
Williams et al., 2014). Understanding how the PN coordinates
the activation of protective components in a systemic manner
is fundamentally important.
Transcellular chaperone signaling (TCS) can be activated by
overexpression of the essential molecular chaperone heat shock
protein 90 (HSP-90) in specific tissues. This generates a form of
tissue-specific proteostatic imbalance that induces non-cell-
autonomous hsp-90 expression and suppresses misfolding of
metastable clients in remote tissues (van Oosten-Hawle et al.,
2013). In this study, we investigated the central question of
how non-cell-autonomous regulation of hsp-90 chaperone
expression is achieved and whether it can be utilized to protect
from the toxic consequences of aggregation-prone human dis-
ease proteins. Which signaling cues are activated in the
‘‘sender’’ cell to initiate TCS-mediated protective mechanisms
in a distal tissue affected by protein misfolding disease?
We identified key components of TCS that are, depending
on the sender tissue, differentially regulated by the transcrip-
tion factor PQM-1. When initiated from the neurons, PQM-1
orchestrates TCS via the innate immunity-associated trans-
membrane protein CLEC-41, whereas TCS initiated from the
intestine depends on the aspartic protease ASP-12. BothReports 23, 3905–3919, June 26, 2018 ª 2018 The Author(s). 3905
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Increased Expression of HSP-90 in
the Neurons, Intestine, or Bodywall Muscle
Activates TCS and Protects against Ab(3-42)
Protein Toxicity in Muscle
(A–D) Phsp-90::GFP expression in control animals
(i and ii), HSP-90::RFPneuro (iii and iv), HSP-
90::RFPint (v and vi), or HSP-90::RFPmuscle (vii and
viii) (A). Scale bar, 50 mm. GFP and hsp-90 mRNA
levels in HSP-90::RFPneuro; Phsp-90::GFP (B), HSP-
90::RFPint; Phsp-90::GFP (C), and HSP-90::
RFPmuscle; Phsp-90::GFP (D) relative to control ani-
mals expressing Phsp-90::GFP.
(B–D) Bar graphs represent the mean of three in-
dependent experiments. Error bars represent ±
SEM. *p < 0.05, ***p < 0.001; ns, not significant.
(E) Paralysis assays of C. elegans expressing
Ab(3-42) in the bodywall muscle (CL2006)
compared to wild-type (N2) or HSP-90::RFPneuro;
Ab(3-42), HSP-90::RFP
int;Ab(3-42), or HSP-90::
RFPmuscle;Ab(3-42). Paralysis data represent SEM
of 3 biological replicates (n = 100 animals). Sta-
tistical significance was determined by Wilcoxon
matched-pairs signed-rank test. *p < 0.05.
(F) Western blot analysis of amyloid beta mono-
meric and oligomeric amyloid beta expression in
day 3 adult control animals (mAb(3-42), HSP-
90::RFPneuro;Ab(3-42), HSP-90::RFP
int;Ab(3-42), or
HSP-90::RFPmuscle;Ab(3-42).
(G) Quantification of oligomers (band at 26.6 kDa)
in mAb(3-42), compared with HSP-90::RFP
neuro;
Ab(3-42), HSP-90::RFP
int;Ab(3-42), or HSP-90::
RFPmuscle;Ab(3-42). Data are expressed as mean
density of the indicated band based from three
independent experiments. Error bars represent
SEM. One-way ANOVA; *p < 0.05.
See also Figure S1.TCS pathways mediate ‘‘transcellular’’ hsp-90 induction in the
muscle and protect against muscle-expressed amyloid protein
misfolding.
RESULTS
Increased Neuron- and Intestine-Specific Expression of
HSP-90 Activates TCS and Suppresses Ab3-42 Toxicity in
Muscle Cells
Activation of TCS in neurons, intestine or muscle cells by ex-
pressing elevated HSP-90::mCherry protein in these tissues
(henceforth called HSP-90::RFPneuro; HSP-90::RFPint or HSP-3906 Cell Reports 23, 3905–3919, June 26, 201890::RFPmuscle) leads to the non-cell-
autonomous induction of a transcriptional
hsp-90 reporter fused to GFP (Phsp-90::
GFP) (Figure 1A). In HSP-90::RFPneuro,
this corresponded to a 30% increase of
HSP-90::RFP protein present in the neu-
rons relative to whole-animal endoge-
nous HSP-90 levels (Figures S1A and
S1B). This resulted in a 2.5-fold induction
of GFPmRNA levels of the transcriptional
Phsp-90::GFP reporter and global hsp-90
mRNA levels, as measured by qRT-PCR(Figure 1B). In comparison, activation of TCS by expressing a
51% increase of HSP-90::RFP protein in the intestine (Figures
S1A and S1B) induced GFP expression 1.3-fold (not significant
[ns]) and hsp-90 levels 1.75-fold (p = 0.06) (Figure 1C). In HSP-
90::RFPmuscle, a 82% increase of HSP-90::RFP relative to
endogenous levels (Figures S1A and S1B) led to the highest in-
duction of the transcriptional Phsp-90::GFP reporter resulting in
5-fold increased expression ofGFPmRNA and a 2-fold induction
of hsp-90 mRNA levels (Figure 1D). Induction of Phsp-90::GFP
transcriptional activity and hsp-90mRNA levels was significantly
higher in HSP-90::RFPneuro (Figures 1A–1D), despite the
fact that the expression level of HSP-90::RFP protein in
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Figure 2. The Zinc-Finger Transcription Factor PQM-1 Mediates TCS in C. elegans
(A) Ab initiomotif discovery with HOMER identifies a significantly enrichedmotif (GATAA) in the promoters of 27 of the 34 genes upregulated inHSP-90::GFPneuro
compared to control (N2).
(B–E) Collapsed z stack images of young adultC. elegans expressing the Phsp-90::GFP reporter in control background (Bi),HSP-90::RFP
neuro (Ci),HSP-90::RFPint
(Di), andHSP-90::RFPmuscle (Ei) compared with expression of the Phsp-90::GFP reporter in a pqm-1(KO)mutant background. Expression of Phsp-90::GFP in a pqm-
1(KO) mutant background (Biv), HSP-90::RFPneuro;pqm-1 (KO) (Civ), HSP-90::RFPint;pqm-1(KO) (Div), or HSP-90::RFPmuscle (Eiv). 203 magnification of the
(legend continued on next page)
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HSP-90::RFPneuro is lower than HSP-90::RFPint or HSP-
90::RFPmuscle (Figures S1A and S1B).
At the level of individual tissues, Phsp-90::GFP reporter expres-
sion in control animals was primarily detected in pharyngeal
tissue and some cells of the intestine during normal growth con-
ditions (20C) (Figures 2Bi–iii). In HSP-90::RFPneuro and HSP-
90::RFPint, expression of Phsp-90::GFPwas particularly increased
in the bodywall muscle, pharynx, and excretory cell and canal,
albeit to a lower extent in HSP-90::RFPint when compared to
HSP-90::RFPneuro (Figures 2Ci–iii and 2Di–iii). In the HSP-
90::RFPmuscle strain, Phsp-90::GFP expression was strongly
induced in the bodywall muscle, indicating a strong cell-autono-
mous induction of hsp-90, in addition to non-cell-autonomous
induction of the reporter in pharynx, excretory cell, and intestine
(Figures 2Ei–2Eiii).
Neuron-Specific and Intestine-Specific Overexpression
of HSP-90 Suppresses Ab3-42 Toxicity in Muscle Cells
via TCS
InC. elegans, expression of humanAb3-42 in the bodywall muscle
leads to age-dependent aggregation and toxicity of the protein,
resulting in decreased motility and paralysis (Link, 1995; McColl
et al., 2012). Amyloid beta (Ab)associated toxicity can be sup-
pressed by PN components (Cohen et al., 2009; Morley et al.,
2002), and depends on hsp-90 expression (Brehme et al.,
2014). We therefore asked whether the TCS-mediated upregula-
tion of hsp-90 in the bodywall muscle in HSP-90::RFPneuro and
HSP-90::RFPint would suppress the toxic consequences of
human Alzheimer’s Ab protein misfolding.
We used a C. elegans model for Alzheimer’s disease, which
expressed the cytotoxic human beta amyloid protein (mAb3-42)
in the C. elegans bodywall muscle (Link, 1995), leading to
increased paralysis with age (Figure 1E). Importantly, overex-
pression of HSP-90::RFP in muscle, intestine, or neurons alone
had no effect on motility throughout aging compared to control
(N2) animals (Figure S1D). HSP-90::RFPmuscle completely abro-
gated mAb3-42-associated paralysis resulting in animals that
behaved similar to control animals (Figure 1E).HSP-90::RFPneuro
significantly suppressed Ab3-42-dependent muscle dysfunction,
with only 25% ofHSP-90::RFPneuro;mAb3-42 animals being para-
lyzed at day 8 of adulthood compared to 45% same agemAb3-42
control animals (Figure 1E). Surprisingly, increased expression of
HSP-90::RFPint led to an equal level of suppression of mAb3-42-
associated toxicity, with 26% of animals being paralyzed at day
8 of adulthood (Figure 1E).
Intrigued by this observation, we determined whether sup-
pression of paralysis in all three HSP-90 overexpression strains
was associated with a decrease of toxic Ab3-42 conformational
variants. HSP-90::RFPmuscle diminished the levels of Ab mono-anterior (head) region (Bii, Bv, Cii, Cv, Dii, Dv, Eii, and Ev). Differential interfer
Phsp-90::GFP expression are indicated with a white arrow. bwm, bodywall muscle
(F–I) Quantification of GFP fluorescence intensity in C. elegans expressing Phsp-
90::RFPneuro;pqm-1(KO) (G), or HSP-90::RFPint;pqm-1(KO) (H), or HSP-90::RFPm
(J–M) GFP and hsp-90 mRNA levels are reduced in HSP-90::GFPneuro;Phsp-90
90::GFPmuscle;Phsp-90::GFP;pqm-1(KO) (M), but not in Phsp-90::GFP;pqm-1(KO) (J
Scale bar, 50 mm (B–E). Bar graphs represent the mean of three independent ex
See also Figure S2.
3908 Cell Reports 23, 3905–3919, June 26, 2018mer and oligomeric species, consistent with the strongly
reduced paralysis in this strain (Figures 1E and 1F), which is likely
a cell-autonomous consequence of HSP-90::RFPmuscle overex-
pression. In HSP-90::RFPneuro and HSP-90::RFPint, accumula-
tion of monomer and smaller oligomeric species (<17 kDa) is
clearly present; however, the accumulation of higher oligomeric
species (26 kDa) was reduced to 60% in HSP-90::RFPneuro and
to 85% in HSP-90::RFPint, compared with a 58% reduction in
HSP-90::RFPmuscle (Figure 1G). Thus, the significant reduction
of higher oligomeric species (26 kDa) in all three HSP-90 overex-
pression strains likely contributes to the suppression of Ab
toxicity.
The Transcription Factor PQM-1 Mediates TCS and
Triggers Innate Immune Gene Expression
To investigate the underlying mechanism that mediates TCS
upon HSP-90 overexpression, we performed RNA sequencing
(RNA-seq) analyses using HSP-90::GFPneuro animals that ex-
press a 46% increase of HSP-90::GFP (Figures S1A and S1B).
RNA-seq analysis identified 225 genes differentially expressed
in HSP-90::GFPneuro relative to N2 control animals (Table S1) of
which 34 genes (excluding 5 pseudogenes) were significantly
upregulated >1.5-fold (p-adj < 0.05) (Table S2). Among these,
the gene ontology (GO) term associated with innate immune re-
sponses was overrepresented (19 out of 34 genes) (Table S2).
Confirmation of gene expression levels by qRT-PCR in HSP-
90::GFPneuro revealed generally lower levels of expression (Fig-
ure S1C), but significant correlation between the qRT-PCR and
RNA-seq measurements (r = 0.55, p = 0.001). Expression levels
of the same genes in HSP-90::RFPneuro were comparable to
those measured inHSP-90::GFPneuro (r = 0.62; p = 0.00008) (Fig-
ure S1C), indicating that a common transcriptional program is
induced upon neuronal HSP-90 overexpression. We performed
hypergeometric optimization of motif enrichment (HOMER) anal-
ysis on the upregulated genes which identified a motif with the
consensus AGATAACA or TGTTATCT enriched in the promoter
regions in 27 of the 34 upregulated genes in HSP-90::GFPneuro
(p = 13 109, found in 28% of targets vs. 0.16% of background)
(Figure 2A). The motif resembled the GATA-like DAE (DAF-16-
associated element) which has been previously identified as
the binding site for the C2H2 zinc-finger transcription factor
PQM-1 (Tepper et al., 2013). Consistent with our finding, a previ-
ous PQM-1 chromatin immunoprecipitation sequencing (ChIP-
seq) analysis confirms binding of PQM-1 to 16 promoters of
genes identified in our dataset (see Table S2) (Niu et al., 2011).
To determine whether PQM-1 is involved in TCS, we used a
pqm-1(ok485) knockout mutant (pqm-1(KO)), which contains
a deletion mutation to remove exons 2 to 6, effectively
depleting expression of pqm-1 transcripts (Figure S1E) (Dowenence contrast (DIC) Nomarski, GFP, RFP overlay images. Tissues showing
; exc, excretory cell; exc canal, excretory canal; ph, pharynx; and int, intestine.
90::GFP in the pqm-1(KO) mutant compared to control background (F), HSP-
uscle;pqm-1(KO) (I) relative to control.
::GFP;pqm-1(KO) (K), HSP-90::GFPint;Phsp-90::GFP;pqm-1(KO) (L), and HSP-
) relative to the Phsp-90::GFP control strain.
periments (F–M). Error bars represent ± SEM. *p < 0.05. ns, not significant.
et al., 2016; Tepper et al., 2013). Depletion of pqm-1 in
C. elegans expressing HSP-90::RFPneuro;Phsp-90::GFP reduced
GFP fluorescence intensity to 40% (Figures 2C, 2G, and S2B)
and to 50% in HSP-90::RFPint;Phsp-90::GFP (Figures 2D, 2H,
and S2C), whereas depletion of pqm-1 in HSP-90::RFPmuscle;
Phsp-90::GFP reduced GFP fluorescence to 75% (Figures 2E,
2I, and S2D), suggesting that pqm-1 mediates TCS. However,
absence of pqm-1 in the Phsp-90::GFP control strain did not affect
GFP fluorescence intensity (Figures 2B, 2F, and S2A).
At the level of individual tissues, pqm-1(KO) in HSP-90::
RFPneuro and HSP-90::RFPint decreased Phsp-90::GFP expres-
sion in excretory cell and canal, pharynx, and bodywall muscle
(Figures 2C and 2D, respectively), whereas inHSP-90::RFPmuscle
this led to a visibly decreased expression of the reporter in
pharynx and intestine (Figure 2E). Pqm-1(KO) in all three TCS-
activated strains resulted in a general reduction of hsp-90
mRNA levels (Figures 2K, 2L, and 2M), reducing global hsp-90
expression back to the basal levels of the control strain (Fig-
ure 2J). The pqm-1(KO) mutation did not affect hsp-90 or GFP
mRNA expression levels in the control strain (Figure 2J), sug-
gesting that pqm-1 does not regulate hsp-90 expression under
normal growth conditions. Consistently, knockdown of pqm-1
by RNAi in the control strain (Figures S2E and S2I), HSP-
90::RFPneuro;Phsp-90::GFP (Figures S2F and S2J), in HSP-90::
RFPint;Phsp-90::GFP (Figures S2G and S2K) or HSP-90::
RFPmuscle;Phsp-90::GFP (Figures S2H and S2L) phenocopied the
effect of the pqm-1(KO) mutation on Phsp-90::GFP reporter and
global hsp-90 mRNA levels.
RNAi-mediated knockdown of hsf-1 or daf-16 had no effect on
GFP fluorescence intensity of the reporter or GFP and hsp-90
mRNA levels in all three TCS-activated strains, whereas hsp-
90 expression in the control strain was dependent on hsf-1 or
daf-16 (Figure S3), confirming that neither DAF-16 nor HSF-1
are involved in TCS (van Oosten-Hawle et al., 2013).
The motif enrichment analysis also identified the FoxA tran-
scription factor PHA-4 (ranked at position 13, p = 1e-5), previ-
ously shown to be required for TCS in C. elegans (van Oosten-
Hawle et al., 2013). However, the PHA-4 consensus sequence
was found in the promoter of only one putative target gene
(Y41C4A.11) (Table S2). To investigate whether pqm-1 and
pha-4 could act in the same genetic pathway to regulate TCS-
induced hsp-90 expression, we knocked down pha-4 by RNAi
in addition to pqm-1(KO), which further reduced GFP and hsp-
90 mRNA levels in all three TCS-activated strains, indicating
that pqm-1 and pha-4 may control TCS via two distinct
pathways.
As pqm-1 mediates TCS in response to tissue-specific HSP-
90 overexpression, we sought to determine whether this was
also the case when hsp-90 is constitutively knocked down (KD)
via tissue-specific hsp-90 hairpin RNAi in the neurons (hsp-
90neuro(KD)) or intestine (hsp-90int(KD)), which leads to systemic
upregulation of hsp-70 (C12C8.1) (Figure S4A) (van Oosten-
Hawle et al., 2013). However, the absence of pqm-1 had no
effect on hsp-70 mRNA expression in hsp-90neuro(KD) and
hsp-90int(KD) (Figure S4A), and pqm-1 mRNA levels were not
affected by tissue-specific knockdown of hsp-90 (Figure S4B).
Thus, PQM-1 mediates TCS specifically in response to tissue-
specific HSP-90 overexpression in the neurons or intestine, butnot in response to reduced expression of hsp-90 in the same
tissues.
PQM-1 Is Required for Stress-Induced hsp-90
Expression and Heat Stress Resistance
PQM-1 complements DAF-16/FOXO to regulate longevity in
C. elegans (Tepper et al., 2013). It is, however, unclear whether
PQM-1 is involved in the regulation of cell stress responses or
the maintenance of proteostasis in general.
We measured mRNA levels of a range of heat-inducible chap-
erones, including stress-inducible hsp-70 (C12C8.1), hsp-90,
the small HSP hsp-16.2, and constitutively expressed Hsp70
(hsp-1), by qRT-PCR after a 1-hr heat shock (HS) at 35C in
pqm-1(KO) mutants (Figures 3A, 3B, S4C, and S4D). While in-
duction of all four chaperones were significantly reduced in the
hsf-1(sy441) mutant that cannot induce a proper HSR (Hajdu-
Cronin et al., 2004), heat-inducible mRNA accumulation of
hsp-70, hsp-1, and hsp-16.2 was comparable between pqm-
1(KO) and wild-type (WT) animals (Figures 3A, S4C, and S4D,
respectively), as well as between the hsf-1(sy441);pqm-1(KO)
mutant and hsf-1(sy441) (Figures 3A, S4C, and S4D), indicating
that stress induction of these chaperones is dependent on func-
tional hsf-1, but not pqm-1. Interestingly, both the pqm-1(KO)
mutant and the hsf-1(sy441);pqm-1(KO) mutant showed signifi-
cant decreases in heat-inducible hsp-90 mRNA compared to
controls (Figure 3B). After HS treatment, hsp-90 was weakly
induced in the hsf-1(sy441)mutant, albeit starting at a 50% lower
basal expression level (Figure 3B). However, hsp-90 mRNA in-
duction after HS remained at its basal expression level in the
pqm-1(KO) and hsf-1(sy441);pqm-1(KO) mutants (Figure 3B),
with HSP-90 protein expression levels equally reduced in the
hsf-1(sy441) and pqm-1(KO) compared to control animals (Fig-
ures S4E and S4F). This indicates that heat-inducible hsp-90
expression is dependent on the presence of pqm-1, while basal
hsp-90 expression depends on functional hsf-1.
Next, we investigated whether loss of pqm-1(KO) has any con-
sequences for HS survival of C. elegans. While 45% of control
animals survived a 6-hr heat shock, only 20% of pqm-1(KO)mu-
tants survived, comparable to animals treated with hsf-1 RNAi
(Figure 3C). RNAi-mediated knockdown of hsf-1 in the pqm-
1(KO) mutant further amplified this effect, with less than 5% of
pqm-1(KO) animals treated with hsf-1 RNAi surviving HS (Fig-
ure 3C). Similar results were obtained for pqm-1(KO) animals
crossed into the genetic background of hsf-1(sy441) mutants
(Figure S4G), indicating that pqm-1 regulates heat stress survival
in a pathway independent or complementary to hsf-1. These re-
sults show that although pqm-1(KO) mutants are capable of
inducing hsp-70 and hsp-16.2 mRNA after HS, the inability of
pqm-1(KO)mutants to induce protective levels of hsp-90 is detri-
mental for survival.
pqm-1 Is Required for Proteostasis Maintenance
To assess whether pqm-1 is required for the age-associated
decline of proteostasis, we used C. elegans expressing Q35::
YFP in the bodywall muscle (Morley et al., 2002). Q35;pqm-
1(KO) animals accumulated an average of 70 aggregates per an-
imal by day 4 of adulthood, whereas Q35::YFP control animals
accumulated 55 aggregates (Figures 3D and 3E). At day 8 ofCell Reports 23, 3905–3919, June 26, 2018 3909
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Figure 3. PQM-1 Regulates Heat-Inducible
Expression of hsp-90 and Is Involved in
Proteostasis
(A and B) mRNA levels of heat-inducible hsp-70
(C12C8.1) (A) or hsp-90 (B) before and after heat
shock (1 hr at 35C) in young adult wild-type, pqm-
1(KO) mutant, hsf-1(sy441) mutant, and pqm-
1(KO);hsf-1(sy441) double-mutant animals relative
to heat-shocked control animals (wild-type, N2).
(C) Thermo-sensitivity of L4 animals (n = 20; five
biological replicates) with indicated genotypes dur-
ing control (EV) or hsf-1 RNAi after exposure to a
35C heat shock for 4, 5, or 6 hr. Survival was
measured after a recovery period of 16 hr at 20C.
(D)Q35::YFP aggregation is enhanced in pqm-1(KO)
mutants. Quantification of accumulated Q35 foci in
age-synchronized day 4 adults of pqm-1(KO) mu-
tants and control animals. *p < 0.05.
(E) Day 4 adult C. elegans expressing Q35::YFP in
the bodywall muscle of control animals (i and iii) and
pqm-1(KO) mutants (ii and iv). 20x magnification of
anterior (head) region of control and pqm-1(KO)
mutants (ii and iv). Scale bar, 50 mm.
(F) Q35-associated toxicity is increased in
pqm-1(KO) mutants. Paralysis was measured in
age-synchronized pqm-1(KO) mutants expressing
Q35::YFP in the bodywall muscle (Q35) compared
with Q35 control animals at the indicated time
points (100 animals per biological replicate, N = 3).
*p < 0.05; **p < 0.01; paired t test. Error bars
represent ± SEM.
*p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001
(A–C). Bar graphs represent combined mean values
of five independent experiments. Error bars repre-
sent ± SEM.
See also Figures S3 and S4.adulthood, 75% of Q35;pqm-1(KO) animals were paralyzed
compared to 50% of control animals, indicating increased
toxicity (Figure 3F). Combined these results show that PQM-1
is a regulatory component of the proteostasis network that is
required for stress survival and maintenance of proteostasis
throughout aging.
Nuclear Localization of PQM-1 Is Increased in the
Intestine of HSP-90::RFPneuro
Our finding that PQM-1-dependent genes are upregulated in
HSP-90::RFPneuro in the neurons indicates that the transcrip-
tional activity of PQM-1 must also be increased. Consistent
with previous reports, we found PQM-1::GFP::FLAG protein nu-
clearly localized in intestinal cells throughout all larval stages (L1
to L4) in WT background, reflecting its active transcriptional role
during development (Dowen et al., 2016; Tepper et al., 2013)3910 Cell Reports 23, 3905–3919, June 26, 2018(Figure 4A). In young pre-reproductive
adults, nuclear localization of PQM-1 be-
comes more diffuse (Figures 4Av and
4Axi) before it completely disappears with
the onset of egg production in day 1 adults
(Figures 4Avi and 4xii). Interestingly, in
TCS-activated adults HSP-90::RFPneuro
(Figures 4Bi and 4Biv) or HSP-90::RFPint(Figures 4Bii and 4Bv) PQM-1 remained localized to the nucleus,
signifying increased transcriptional activity, whereas no nuclear
distribution of PQM-1 is observed in HSP-90::RFPmuscle (Fig-
ure 4B, iii and vi) or WT animals (Figures 4Avi and 4Axii). Quanti-
fication revealed that 25%of PQM-1::GFP::FLAG remained in in-
testinal nuclei in HSP-90::RFPneuro and 20% in HSP-90::RFPint,
compared to only 5% nuclear PQM-1 in the control strain and
10% (ns) in HSP-90::RFPmuscle (Figure 4C). However, PQM-1::
GFP::FLAG protein levels remained constant across WT and
TCS-activated strains (Figure 4D). Therefore, PQM-1 nuclear
localization and presumably transcriptional activity is extended
into reproductive adulthood through neuron- or intestine-spe-
cific overexpression of HSP-90.
Because pqm-1 is required for resistance to the pathogenic
bacteria Pseudomonas aeruginosa (Shapira et al., 2006), we
asked whether the TCS-activated strains exhibiting increased
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Figure 4. PQM-1::GFP::FLAG Remains
Nuclearly Localized in the Intestine of
Young Adult C. elegans Expressing HSP-
90::RFPneuro or HSP-90::RFPint
(A) Expression of PQM-1::GFP::FLAG (strain
OP201) during larval stages L1(i and vii), L2 (ii and
viii), L3 (iii and ix), and L4 (iv and x). PQM-1::GFP
nuclear localization becomes diffuse in early pre-
reproductive adults (56 hr after hatching at 20C)
(v and xi) and disappears in day 1 adults (65 hr after
hatching) (vi and xii). Scale bar, 20 mm (i–iii). Scale
bar, 50 mm (iv-vi). Yellow arrows denote eggs
present in the day 1 adult.
(B) PQM-1::GFP::FLAG localizes to intestinal
nuclei in TCS-activated strains HSP-90::RFPneuro
(i and iv), HSP-90::RFPint (ii and v), and HSP-
90::RFPmuscle (iii and vi). Scale bar, 50 mm. Yellow
arrows indicate eggs.
(C)PQM-1::GFP::FLAG inHSP-90::RFPneuro,HSP-
90::RFPint, or HSP-90::RFPmuscle was scored for
nuclear and cytosolic localization and compared
to the control strain (n > 20 per strain). *p < 0.05;
**p < 0.01; Kruskal-Wallis test. Error bars repre-
sent ± SEM.
(D) Western blot analysis of PQM-1::GFP::FLAG in
TCS-activated strains compared to control ani-
mals using an anti-FLAG antibody. Tubulin was
used as a loading control.nuclear PQM-1 localization were more resistant. Only HSP-
90::RFPneuro showed increased survival to P. aeruginosa (Fig-
ure S4H), consistent with the higher measured PQM-1 nuclear
localization in this strain (Figures 4B and 4C). Depletion of
pqm-1 in HSP-90::RFPneuro, but not in control WT animals,
reversed this effect (Figure S4H). Although PQM-1 nuclear local-
ization is also induced in HSP-90::RFPint, it is lower when
compared to HSP-90::RFPneuro (Figures 4B and 4C) and may
not be sufficient for an effective innate immune response.
Neuron- and Intestine-Specific HSP-90 Overexpression
Triggers PQM-1 Transcriptional Activity in the Same
Tissue to Regulate Systemic TCS
PQM-1 is expressed in the intestine and neuronal cells (Reece-
Hoyes et al., 2007; Tepper et al., 2013), although we could not
detect PQM-1::GFP::FLAG expression by fluorescence micro-
scopy in C. elegans neurons. We therefore wanted to determine
whether PQM-1 is required in the neurons or the intestine ofCell ReHSP90::RFPneuro animals for TCS-medi-
ated hsp-90 induction in other tissues.
Moreover, we considered the possibility
that PQM-1 is activated in the bodywall
muscle, where Phsp-90::GFP expression
is largely induced as a consequence
of TCS (Figures 2B–2D). We therefore
generated C. elegans strains in which
the effects of RNAi are restricted to
neurons (HSP-90::RFPneuro;Phsp-90::GFP,
sid-1(pk3321);unc-119p::SID-1) (Calixto
et al., 2010), or intestine (HSP-90::
RFPneuro;Phsp-90::GFP, sid-1(pk3321);vha-6p::SID-1), or bodywall muscle (HSP-90::RFPneuro;
Phsp-90::GFP, sid-1(pk3321);unc-54p::SID-1).
To confirm that tissue-specific RNAi was indeed restricted to
neurons, intestine, or muscle, we exposed the aforementioned
C. elegans strains to hsp-90 RNAi and measured tissue-spe-
cific HSP-90::RFP fluorescence intensity (Figure S5). For
example, HSP-90::RFP fluorescence intensity in the neurons
was reduced to 25% by systemic hsp-90 RNAi (Figures S5Aa
and S5Ab) and to 30% by neuron-specific hsp-90 RNAi (Fig-
ures S5Ca and S5Cb), but had no effect upon intestine-specific
or muscle-specific hsp-90 RNAi (Figures S5Da and S5Db and
Figures S5Ea and S5Eb, respectively). Consistently, hsp-90
RNAi in the RNAi-resistant control strain HSP-90::RFPneuro;
Phsp-90::GFP;sid-1(pk3321) did not reduce HSP-90::RFP
expression (Figures S5Ba and S5Bb). Similar results showing
the tissue specificity of this RNAi approach were also ob-
tained in HSP-90::RFPint and HSP-90::RFPmuscle strains (see
Figure S5).ports 23, 3905–3919, June 26, 2018 3911
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Neuron-specific pqm-1 RNAi in HSP-90::RFPneuro effectively
reduced GFP fluorescence intensity of the Phsp-90::GFP reporter
compared to animals treated with control RNAi (Figure 5A), cor-
responding to a 40% reduction of both GFP and hsp-90 mRNA
levels (Figure 5D). Interestingly, intestine-specific knockdown
of pqm-1 by RNAi in HSP-90::RFPneuro had no effect on
Phsp-90::GFP reporter expression (Figure 5B) or GFP and
hsp-90 mRNA levels (Figure 5E). These results suggest that
PQM-1 is required in the neurons, but not the intestine, of
HSP-90::RFPneuro to mediate TCS-induced hsp-90 expression
in distal tissues. The higher distribution of PQM-1 to intestinal
nuclei in this strain (Figures 4B and 4C) may be a consequence
of TCS but is not required for TCS-mediated hsp-90 expression.
Intestine-specific pqm-1 RNAi in HSP-90::RFPint reduced
GFP fluorescence intensity of the Phsp-90::GFP reporter (Fig-
ure 5H) which corresponded to a 50% decrease of GFP and
hsp-90mRNA expression relative to control animals (Figure 5K).
However, neuron-specific pqm-1 RNAi in the same strain left
Phsp-90::GFP reporter expression unchanged (Figure 5G) and
had no effect on GFP or hsp-90 mRNA expression levels (Fig-
ure 5J). Combined, these results indicate that PQM-1 may be
activated in the same tissue that overexpresses HSP-90::RFP
to induce TCS, but does not require PQM-1 to be expressed
in other tissues for TCS. Interestingly, muscle-specific pqm-1
RNAi had no effect on TCS-mediated hsp-90 expression in
HSP-90::RFPneuro (Figures 5C and 5F), HSP-90::RFPint (Figures
5I and 5L) or HSP-90::RFPmuscle (Figures 5O and 5R). This indi-
cates that neurons and intestine are key tissues for TCS and
suggests that PQM-1 indirectly regulates hsp-90 expression in
the muscle.
PQM-1 Indirectly Regulates TCS-Induced hsp-90
Expression inMuscle via Innate Immune Factors clec-41
and asp-12
Next, we investigated whether PQM-1 directly regulates TCS-
induced hsp-90 expression by binding to a putative PQM-1
bindingmotif 119–129 bp upstream of the TSS in the hsp-90 pro-
moter. Therefore we generated a transcriptional reporter con-
taining the native hsp-90 promoter region upstream of GFP,
Phsp-90(WT)::GFP, or lacking the putative PQM-1 binding motif
sequence, Phsp-90(del)::GFP (Figure S6A). Phsp-90(del)::GFP re-
porter animals did however not show a significant change in
GFP intensity relative to the native Phsp-90(WT)::GFP reporterFigure 5. PQM-1 Is Required in the Neurons in HSP-90::RFPneuro and in
(A–C) Expression of the Phsp-90::GFP transcriptional reporter in HSP-90::RFP
neur
bodywall muscle (C).
(D–F) Transcript levels ofGFP and hsp-90 inHSP-90::RFPneuro;Phsp-90::GFP durin
or pqm-1 RNAi. *p < 0.05; ns, non-significant. Bar graphs represent combined m
(G–I) Expression of the Phsp-90::GFP transcriptional reporter in HSP-90::RFP
int a
intestine (H), or bodywall muscle (I).
(J–L) Transcript levels of GFP and hsp-90 during neuron-specific (J), intestin
90::RFPint;Phsp-90::GFP.
(M–O) Expression of the Phsp-90::GFP transcriptional reporter in HSP-90::RFP
musc
intestine (N), or bodywall muscle (O).
(P–R) Transcript levels of GFP and hsp-90 mRNA in HSP-90::RFPmuscle;Phsp-90:
control (EV) or pqm-1 RNAi. *p < 0.05; ns, non-significant. Bar graphs represent
Error bars represent ± SEM (A–C, G–I, and M–O). Scale bar, 50 mm.
See also Figures S5 and S6.(Figures S6B and S6D). Although both the native or modified
Phsp-90::GFP reporter exhibited a significant upregulation of
Phsp-90::GFP expression in the bodywall muscle and pharyngeal
tissues when crossed into HSP-90::RFPneuro (Figure S6C), this
TCS-mediated hsp-90 induction was similar between the native
and modified reporter constructs (Figures S6C, S6D, and S6E).
Thus, deletion of the putative PQM-1 binding motif in the
hsp-90 promoter had no effect on TCS-mediated hsp-90
expression in distal tissues, corroborating the idea that PQM-1
indirectly controls hsp-90 expression possibly via a pqm-1-regu-
lated effector.
To examine this possibility further, we performed an RNAi
mini-screen of the 16 genes identified in our RNA-seq dataset
that contain a PQM-1 binding motif in their promoters (Niu
et al., 2011) (Table S2). We identified three hits, namely
F21F8.4 (asp-12), B0365.6 (clec-41), and B0285.9 (ckb-2) that
upon RNAi-mediated knockdown reduced GFP fluorescence
by more than 50% in HSP-90::RFPneuro;Phsp-90::GFP (Figure 6A
and Figure S7A). mRNA expression of all three genes are
induced in HSP-90::RFPneuro;Phsp-90::GFP (Figure 6B) and
RNAi-mediated knockdown of pqm-1 reduced mRNA expres-
sion of all three genes back to control levels (Figure 6B), confirm-
ing the requirement for pqm-1 to regulate their expression. Sys-
temic ckb-2, asp-12, or clec-41 RNAi in HSP-90::RFPneuro
reduced Phsp-90::GFP (Figure S7A), as well as GFP and hsp-90
mRNA expression relative to control RNAi, indicating their
involvement in TCS-mediated hsp-90 induction (Figure 6D).
PQM-1 Orchestrates Neuron-Activated TCS via PQM-1/
CLEC-41 and Intestine-Activated TCS via PQM-1/ASP-
12 Signaling
HSP-90::RFPneuro requires PQM-1 in the neurons to trigger TCS;
therefore, we tested whether neuronal expression of ckb-2, asp-
12, or clec-41 is required in the neurons for TCS-mediated hsp-
90 induction in the muscle. Strikingly, neuron-specific RNAi of
only one of the gene hits, clec-41, reduced TCS-induced hsp-
90 expression (Figure 6E). At the level of individual tissues this
corresponded to reduced expression of the Phsp-90::GFP re-
porter in bodywall muscle and pharynx, indicating the require-
ment for clec-41 expression in the neurons to mediate TCS-
induced expression of hsp-90 in muscle (Figures 6F and S7C).
Simultaneous clec-41 and pqm-1 RNAi did not lead to further
reduction of TCS activity (Figure 6J), suggesting that pqm-1the Intestine in HSP-90::RFPint to Induce TCS
o during tissue-specific control or pqm-1 RNAi in neurons (A), intestine (B), or
g neuron-specific (D), intestine-specific (E), andmuscle-specific (F) control (EV)
ean values of three independent experiments. Error bars represent ± SEM.
dults during tissue-specific control RNAi (EV) or pqm-1 RNAi in neurons (G),
e-specific (K), or muscle-specific (L) control (EV) or pqm-1 RNAi in HSP-
le adults during tissue-specific control RNAi (EV) or pqm-1 RNAi in neurons (M),
:GFP during neuron-specific (P), intestine-specific (O), or muscle-specific (R)
combined mean values of three independent experiments.
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Figure 6. pqm-1-Regulated Genes Are Required for TCS-Induced hsp-90 Expression
(A) Quantification of Phsp-90::GFP fluorescence intensity in HSP-90::RFP
neuro;Phsp-90::GFP animals during RNAi-mediated knockdown of indicated 16 genes
relative to control (EV) RNAi. Scored hits (clec-41, asp-12, and ckb-2) show less than 50% GFP fluorescence intensity.
(legend continued on next page)
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and clec-41 function in the same signaling pathway to regulate
TCS-mediated hsp-90 induction.
Because HSP-90::RFPint induces TCS in a pqm-1 dependent
manner, we sought to determine whether ckb-2, asp-12 or
clec-41 could also play a role in TCS-mediated hsp-90 expres-
sion in HSP-90::RFPint. Indeed, both ckb-2 and asp-12 expres-
sion were upregulated (Figure 6C). Systemic ckb-2 or asp-12
RNAi significantly reduced GFP mRNA expression in HSP-
90::RFPint;Phsp-90::GFP, with asp-12RNAi leading to a significant
50% decrease of global hsp-90 mRNA expression relative to
control RNAi (Figures 6G and S7D). Intestine-specific ckb-2
RNAi was ineffective, but intestine-specific asp-12 RNAi
reduced global hsp-90 levels to 75% (Figure 6H), and reduced
Phsp-90::GFP reporter expression in muscle cells (Figures 6I
and S7E). Simultaneous asp-12 and pqm-1RNAi led to no further
reduction of hsp-90 or GFPmRNA expression levels, confirming
that asp-12 and pqm-1 likely function in the same intestine-acti-
vated TCS pathway (Figure 6K). Importantly, the neuron-induced
TCS route was unaffected via intestine-specific clec-41 or asp-
12 RNAi (Figure S7I), whereas intestine-activated TCS was unaf-
fected by neuron-specific clec-41 or asp-12 RNAi (Figure S7J),
demonstrating that both TCS routes function independent of
each other and are differentially regulated.
Neuron-Induced TCS Promotes Non-cell-autonomous
hsp-90 Expression through Glutamate-Mediated
Neurotransmission
We have previously shown that TCS-mediated hsp-90 expres-
sion is controlled independently of dense-core vesicle unc-31-
or small core vesicle unc-13- mediated neuro-secretion (van
Oosten-Hawle et al., 2013), yet neuron-induced TCS regulates
hsp-90 expression in distal tissues via neuronally activated
PQM-1/CLEC-41 signaling. One explanation for this discrepancy
is that upon depletion of unc-31-mediated dense core vesicle
neuro-secretion the unc-13-mediated small core vesicle route
is still active and so compensates for loss of the other and vice
versa. Depletion of unc-31 had no effect on TCS-mediated
hsp-90 or GFP mRNA expression (Figures S7F–S7H) (van Oos-
ten-Hawle et al., 2013), and additional RNAi-mediated knock-(B) mRNA levels of ckb-2 (B0285.9) and innate immune factors asp-12 (F21F8.4) a
or pqm-1 RNAi.
(C) Total mRNA levels of pqm-1-regulated kinase ckb-2 (B0285.9) and innate imm
animals treated with control or pqm-1 RNAi.
(D) Whole-animal (systemic) RNAi knockdown of ckb-2, asp-12, or clec-41 in HS
(E) Neuron-specific RNAi of clec-41, but not ckb-2 or asp-12, reduces GFP an
SID-1.
(F) Collapsed z stack images ofHSP-90::RFPneuro;Phsp-90::GFP;sid-1(pk3321);unc
RNAi (iv). 20x magnification of the anterior (head) region (ii and v). Differential int
(G) Whole-animal (systemic) RNAi knockdown of ckb-2 and asp-12 in HSP-90int;
(H) Intestine-specific RNAi of asp-12, but not ckb-2, reduces GFP and hsp-90 m
(I) Collapsed z stack images of HSP-90::RFPint;Phsp-90::GFP;sid-1(pk3321);vha-6
(iv). 20x magnification of the anterior (head) region (ii and v). Differential interfere
(J) Simultaneous pqm-1 and clec-41 RNAi (1:1 ratio) does not further reduce GF
(K) Simultaneous pqm-1 and asp-12 RNAi (1:1 ratio) does not further reduce GF
(L) GFP and hsp-90 transcript levels in HSP-90::RFPneuro; Phsp-90::GFP animals
1(ok371) mutants relative to control animals.
Bar graphs represent combined mean values of three independent experiments (
*p < 0.05; ns, not significant.
See also Figure S7.down of unc-13 in the neurons of these strains did not alter global
hsp-90 or GFPmRNA expression (Figures S7F–S7H). Neverthe-
less, a signal needs to be transmitted from neurons to distal
tissues in HSP-90::RFPneuro. We therefore tested neurotrans-
mitter-mediated pathways previously identified to be required
for systemic stress signaling in C. elegans, such as serotonergic
and octopaminergic signaling (Sun et al., 2012; Tatum et al.,
2015b) for their involvement in TCS. HSP-90::RFPneuro animals
deficient for serotonergic signaling via deletion of the metabo-
tropic serotonin receptor ser-1, exhibited increased global
GFP and hsp-90 mRNA expression (Figure 6L), similar to HSP-
90::RFPneuro animals deficient for octopaminergic signaling, via
depletion of the G-protein-coupled receptor octr-1 (Figure 6L).
Thus, serotonergic and octopaminergic signaling are both
involved in TCS; however, they may function as suppressors
rather than facilitators.
The innate immune peptide CLEC-41 is a predicted plasma
membrane-associated protein containing two beta-barrel form-
ing domains known as ‘‘CUB domains,’’ which are found almost
exclusively in extracellular and plasma membrane-associated
proteins (Bork and Beckmann, 1993) and enriched in the neurons
and intestine (Reece-Hoyes et al., 2007; Spencer et al., 2011).
Interestingly, other neuronally expressed CUB domain proteins
in C. elegans, e.g., sol-1, are known to participate in the gating
mechanism for ions to pass through AMPA-type glutamate re-
ceptors (Zheng et al., 2006). We therefore investigated the
role of glutamatergic signaling for TCS and used a glr-1 mutant
that expresses a non-functional version of the ionotropic
AMPA-type glutamate receptor (Rongo et al., 1998) in HSP-
90::RFPneuro. This decreased GFP and global hsp-90 mRNA
expression by 25% relative to the control (Figure 6L), suggesting
that glutamatergic signaling is indeed a neuronal signaling route
required for TCS.
TCS via Neuronal PQM-1/CLEC-41 Signaling and
Intestinal PQM-1/ASP-12 Signaling Protects against
mAb-Associated Toxicity
Neuron-induced and intestine-induced TCS mediate hsp-90 in-
duction in the muscle, thereby alleviating muscle-expressednd clec-41 (B0354.5) in HSP-90neuro;Phsp-90::GFP animals treated with control
une factors asp-12 (F21F8.4) and clec-41 (B0354.5) in HSP-90int;Phsp-90::GFP
P-90neuro;Phsp-90::GFP reduces transcript levels of GFP and hsp-90.
d hsp-90 mRNA levels in HSP-90neuro;Phsp-90::GFP;sid-1(pk3321);unc-119p::
-119p::SID-1 animals allowing for neuron-specific EV control RNAi (i) or clec-41
erference contrast (DIC) Nomarski GFP, RFP overlay images (iii and vi).
Phsp-90::GFP reduces GFP and hsp-90 mRNA levels.
RNA levels in HSP-90int;Phsp-90::GFP sid-1(pk3321);vha-6p::SID-1.
p::SID-1 animals allowing for intestine-specific control RNAi (i) or asp-12 RNAi
nce contrast (DIC) Nomarski images (iii and vi).
P mRNA and hsp-90 mRNA levels in HSP-90neuro;Phsp-90::GFP.
P mRNA and hsp-90 mRNA levels in HSP-90int;Phsp-90::GFP.
crossed into the genetic background of glr-1(n2461), ser-1(ok345), or octr-
B–E, G, H, J, K, and L). Error bars represent ± SEM. ****p < 0.0001; **p < 0.01;
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Figure 7. The pqm-1-Regulated Immune
Factors clec-41 and asp-12 Are Required
for Neuron- and Intestine-Induced TCS,
Respectively, to Protect against Ab (3-42)
Toxicity in the Muscle
(A) pqm-1 RNAi exacerbates paralysis of HSP-
90::RFPneuro;Ab(3-42) compared with control (EV)
RNAi.
(B) clec-41 RNAi exacerbates paralysis of Ab(3-42)
animals overexpressing HSP-90 in the neurons
(HSP-90::RFPneuro;Ab(3-42)).
(C) pqm-1 RNAi exacerbates paralysis of HSP-
90::RFPint;Ab(3-42).
(D) asp-12 RNAi exacerbates paralysis of Ab(3-42)
animals overexpressing HSP-90 in the intestine
(HSP-90::RFPint;Ab(3-42)).
(A–D) Paralysis data error bars represent SEM of 3
biological replicates (>100 animals per replicate).
Statistical significance was determined by Wil-
coxonmatched-pairs signed-rank test, comparing
HSP-90::RFPneuro;Ab(3-42) grown on pqm-1 or
clec-41 RNAi or HSP-90::RFPint;Ab(3-42) grown on
pqm-1 or asp-12 RNAi with control (EV) RNAi. *p <
0.05, **p < 0.01.
(E) Model explaining neuron-induced TCS activa-
tion of hsp-90 chaperone expression in themuscle
via PQM-1/CLEC-41 signaling. (1) Neuronal over-
expression of HSP-90::RFP induces PQM-1 ac-
tivity locally. (2) Increased PQM-1 activity in the
neurons induces transcription of clec-41, which
aids in the transmission of a ‘‘transcellular chap-
erone signal’’ (3) that activates hsp-90 expression
in muscle cells (4) to protect them from Ab(3-42)-
associated toxicity.
(F) Model explaining intestine-induced TCS acti-
vation of hsp-90 in the muscle via PQM-1/ASP-12
signaling. (1) Intestine-specific overexpression of
HSP-90::RFP induces PQM-1 activity cell auton-
omously in the intestine. (2) Active PQM-1 in the
intestine induces transcription of asp-12, which is
(3) required to induce hsp-90 expression in muscle
cells (4) to protect them from Ab(3-42)-associated
toxicity.mAb3-42 -associated toxicity (Figure 1E). Remarkably, pqm-1 or
clec-41 RNAi in the TCS-activated HSP-90::RFPneuro;mAb3-42
strain exacerbated paralysis (Figures 7A and 7B, respectively)
reversing the protective effect of neuron-induced TCS. While
23% of HSP-90::RFPneuro;mAb3-42 animals grown on control
RNAi were paralyzed at day 8 of adulthood, pqm-1 RNAi in
HSP-90::RFPneuro;mAb3-42 abolished the TCS-mediated protec-
tive effect by increasing the amount of paralysed HSP-90::
RFPneuro;mAb3-42 animals to 38% (Figure 7A), comparable to
mAb3-42 control animals (Figure 7A). Likewise, pha-4 RNAi
reversed the protective effect of HSP-90::RFPneuro on amyloid
toxicity in the bodywall muscle (Figure S7K). Clec-41 RNAi re-
sulted in 50% of HSP-90::RFPneuro;mAb3-42 animals being para-
lyzed at day 8 (Figure 7B), reducing the TCS-mediated protection
against amyloid toxicity. However, pqm-1 or clec-41 RNAi
in mAb3-42 control animals alone did not further increase the
fraction of paralysed mAb3-42 animals (Figures 7A and 7B), indi-
cating that the protective effect via PQM-1/CLEC-41 signaling3916 Cell Reports 23, 3905–3919, June 26, 2018was specific to neuronal activation of TCS. Strikingly, pqm-1
and asp-12 RNAi during intestine-induced TCS led to an
even more severely exacerbated paralysis of HSP-90::RFPint;
mAb3-42 compared to the mAb3-42 control strain (Figures 7C
and 7D, respectively). In summary, our data show that neuron-
induced TCS mediates suppression of amyloid protein-associ-
ated toxicity via hsp-90 induction in the muscle dependent
on neuronal PQM-1/CLEC-41 signaling, while the same effect
via intestine-induced TCS is dependent on PQM-1/ASP-12
signaling.
DISCUSSION
Our study identified key components of signaling cues that regu-
late transcellular activation of hsp-90 chaperone expression in
C. elegans. We identified PQM-1 as amediator of TCS that differ-
entially orchestrates the induction of innate immune peptides to
promote hsp-90 expression in distal tissues. Activation of TCS in
the neurons requires the plasma-membrane-associated innate
immune peptide CLEC-41 in the neurons (Figure 7E), while
activation of TCS in the intestine depends on the aspartic prote-
ase ASP-12 to induce hsp-90 expression in distal tissues
(Figure 7F). Both TCS cues—the neuron-activated PQM-1/
CLEC-41 signaling cue and the intestine-activated PQM-1/
ASP-12 signaling pathway—induce hsp-90 in muscle cells to
ameliorate Ab3-42 -associated toxicity and reduce the accumula-
tion of toxic oligomeric amyloid species.
The PQM-1-dependent TCS network appears to require
PQM-1 activity in the stressed sender tissue and not the re-
sponding tissue (Figures 7E and 7F).While hsp-90 is ubiquitously
expressed in C. elegans (Casanueva et al., 2012; Mendenhall
et al., 2015; van Oosten-Hawle et al., 2013), expression of
pqm-1 overlaps with hsp-90 only in neuronal and intestinal tissue
(Reece-Hoyes et al., 2007; Spencer et al., 2011). Moreover,
pqm-1 does not appear to be required in the muscle to directly
regulate hsp-90 expression. Further evidence arguing against
the possibility of PQM-1 directly regulating hsp-90 expression,
is provided via deletion of the putative PQM-1 GATA binding
site in the hsp-90 promoter. However, before completely
excluding this possibility, a more detailed promoter analysis
that includes >1000 bp of the hsp-90 promoter or ChIP-seq ex-
periments will be needed to characterize PQM-1’s role in the in-
duction of stress-induced hsp-90 expression. To this end, our
data suggest that PQM-1 regulates hsp-90 expression via an in-
direct mechanism that involves pqm-1 regulated innate immune
genes asp-12 and clec-41.
While neither ASP-12 nor CLEC-41 act as the ‘‘transcellular
chaperone activating signal’’ itself, as neither are predicted
secreted peptides (Table S2), both could facilitate the trans-
mission of a ‘‘signal’’ to other tissues. As a CUB domain con-
taining protein expressed in neurons (Zheng et al., 1999),
CLEC-41 could be a factor that facilitates neuron-activated
TCS via glutamatergic signaling. Future work should define
the neuron-specific function for CLEC-41 in TCS in more
detail.
Many known PQM-1 target genes are associated with the
innate immune response (Niu et al., 2011; Shapira et al., 2006;
Templeman et al., 2018) and are also identified in our TCS-
induced dataset. While our results indicate a clear requirement
for pqm-1 forP. aeruginosa resistance during neuronal activation
of TCS, this is not the case in the pqm-1(KO) mutant alone (Fig-
ure S4H) and contrary to a previous report (Shapira et al., 2006).
This discrepancy may however stem from differences in strain
backgrounds used (pqm-1(KO) versus pqm-1 RNAi in a glp-4
(bn2);rrf-3 mutant) and different assay temperatures (20C vs.
25C). It may be that an increased temperature (25C) poses
an additional challenge that affects pqm-1-dependent survival
on pathogenic bacteria.
Our discovery of PQM-1 as an important component of the
PN reveals that metazoans make use of non-canonical stress
transcription factors that function complementary to HSF-1
and DAF-16 to control proteostasis. For example, HSP-90 chap-
erone expression can be regulated by the myogenic transcrip-
tion factor HLH-1 during C. elegans muscle development (Bar-
Lavan et al., 2016) and by PHA-4 during TCS (van Oosten-Hawle
et al., 2013).Moreover, C. elegans utilizes multiple regulatory pathways to
specify the type of stress-response activated in remote cells.
For example, DAF-16-mediated stress-resistance is separated
from HSF-1-mediated activity through a distinct chemosensory
neuronal circuit (Volovik et al., 2014), whereas HSF-1 uses
a thermo-sensory circuit to promote non-cell-autonomous
expression of HSPs (Douglas et al., 2015; Prahlad andMorimoto,
2011; Prahlad et al., 2008). Likewise, activation of UPR path-
ways in response to bacterial infection utilizes octopaminergic
signaling (Sun et al., 2012).
Similar to the differential regulatory cues initiated via HSF-1 or
DAF-16, stress conditions that activate TCS also utilize more
than one regulatory mechanism. TCS-mediated hsp-90 expres-
sion via PHA-4 is regulated differently from the PQM-1-depen-
dent signaling routes described here.Moreover, neuronal activa-
tion of TCS triggers a PQM-1-dependent signaling route that
relies on CLEC-41 and glutamatergic signaling, whereas activa-
tion of TCS from the intestine requires ASP-12 as a key transcel-
lular signaling node.
In neuron-activated TCS, global hsp-90 expression is
induced 2.5-fold, whereas hsp-90 expression is induced 1.75-
fold in HSP-90::RFPint, which is lower compared to our previ-
ous study using the same strain (van Oosten-Hawle et al.,
2013). It is possible that this measured discrepancy is due
to suppressor mutations that have accumulated in HSP-
90::RFPint. Despite this difference in the level of hsp-90 induc-
tion, both HSP-90::RFPint and HSP-90::RFPneuro induce TCS,
which results in a substantial and similar suppression of the
toxic effects of Ab expression in the muscle in both strains (Fig-
ures 1E–1G), comparable to the previously observed suppres-
sion of metastable myosin misfolding in muscle (van Oosten-
Hawle et al., 2013). Although monomer and smaller oligomeric
Ab species (< 17 kDa) are unaffected by TCS-induced hsp-90
expression in HSP-90::RFPneuro and HSP-90::RFPint, both
significantly reduce the accumulation of higher Ab oligomers
(>26 kDa). Thus HSP-90 may be involved in the assembly of
Ab oligomers, as has been suggested in vitro (Evans et al.,
2006), and this may be comparable to the suppressive effect
of HSP-16.2 overexpression in the Ab3-42 C. elegans model
(Fonte et al., 2008). In this light, it is also interesting to note
that increased expression of the HSP90 co-chaperone STI1
protects against the toxic effects of Ab expression in neuronal
cells and a mouse model of Alzheimer’s disease (Ostapchenko
et al., 2013). Further work would be required to understand how
HSP-90 reduces formation of Ab oligomers in vitro and in vivo.
Moreover, it would be interesting to determine whether modu-
lation of the neuronal PQM-1/CLEC-41 or the intestinal PQM-1/
ASP-12 pathway, via genetic activation or small molecules
could provide an avenue for the treatment of protein misfolding
diseases.
EXPERIMENTAL PROCEDURES
C. elegans Growth Conditions
C. elegans were grown on nematode growth media (NGM) plates seeded with
the E. coli OP50-1 strain and cultured by standard methods (Brenner, 1974).
Strains were obtained from the Caenorhabditis Genetic Center (CGC). For a
detailed description of C. elegans strains generated in this study, please refer
to Supplemental Experimental Procedures.Cell Reports 23, 3905–3919, June 26, 2018 3917
RNAi Experiments
For RNAi-mediated knockdown of indicated genes, 50 synchronized L1 ani-
mals were placed on E. coli strain HT115(DE3), which was transformed with
the appropriate RNAi vector (J. Ahringer, University of Cambridge, Cambridge,
UK), as described previously (van Oosten-Hawle et al., 2013). For RNAi-medi-
ated knockdown of hsp-90 or hsf-1, L4 stage larvae instead of L1 larvae were
placed on the appropriate RNAi.
qRT-PCR
RNAwas extracted using TriZOL reagent and grindingC. elegans using a pellet
grinder on ice 33 for 30 s. RNA was then purified using the Zymo-prep RNA
Mini Isolation kit (Zymo Research, Cambridge Biosciences). qRT-PCR was
essentially performed as described previously (vanOosten-Hawle et al., 2013).
Statistical Analysis
All experiments were repeated at least three times (3 biological replicates).
Data are presented as mean values ± SEM. p values were calculated using
Student’s t test. * denotes p < 0.05; ** denotes p < 0.01, and *** denotes p <
0.001; (ns) denotes non-significant. To compare two independent popula-
tions (paralysis assays), we calculated p values using the Wilcoxon Mann-
Whitney rank-sum test. Prism (v.7) software was used for all statistical
analysis.
Detailed protocols for all the methods are provided in the Supplemental
Experimental Procedures.
DATA AND SOFTWARE AVAILABILITY
The accession number for the full RNA-seq dataset reported in this study is
GEO: GSE108005.
SUPPLEMENTAL INFORMATION
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seven figures, and two tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2018.05.093.
ACKNOWLEDGMENTS
We thank Dr. Richard I. Morimoto for his support during the early stages of
this project. P.v.O.-H. was funded by grants from the NC3Rs (NC/P001203/1)
and by a Wellcome Trust Seed Award (200698/Z/16/Z). D.O. was supported
by a Leeds 110 studentship. J.M. was supported by a MRC DiMeN doctoral
training partnership (MR/N013840/1); S.G. was supported by a BBSRC-
Whiterose doctoral training parternship (BB/M011151/1); and L.M.J. was
supported by the NC3Rs. Some C. elegans strains used in this research
were provided by the Caenorhabditis Genetics Center, which is funded by
the NIH Office of Research Infrastructure Programs (P40 OD010440). The
P. aeruginosa strain PA14 was a kind gift of Dr. Maria Gravato-Nobre (Hert-
ford College, Oxford).
AUTHOR CONTRIBUTIONS
Conceptualization, D.O. and P.v.O.-H.; Methodology, D.O., L.M.J., S.G., J.M.,
R.A., C.E.S., M.S.V., D.R.W., and P.v.O.-H.; Investigation, D.O., L.M.J., S.G.,
J.M., R.A., C.E.S., M.S.V., D.R.W., and P.v.O.-H.; Writing – Original Draft,
D.O. and P.v.O.-H.; Writing – Review and Editing, Project Administration, Visu-
alization, Supervision, and Funding Acquisition, P.v.O.-H.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: January 2, 2018
Revised: May 4, 2018
Accepted: May 30, 2018
Published: June 26, 2018.3918 Cell Reports 23, 3905–3919, June 26, 2018REFERENCES
Akerfelt, M., Morimoto, R.I., and Sistonen, L. (2010). Heat shock factors: inte-
grators of cell stress, development and lifespan. Nat. Rev. Mol. Cell Biol. 11,
545–555.
Bar-Lavan, Y., Shemesh, N., Dror, S., Ofir, R., Yeger-Lotem, E., and Ben-Zvi,
A. (2016). A differentiation transcription factor establishes muscle-specific
proteostasis in Caenorhabditis elegans. PLoS Genet. 12, e1006531.
Bork, P., and Beckmann, G. (1993). The CUB domain. A widespread module in
developmentally regulated proteins. J. Mol. Biol. 231, 539–545.
Brehme, M., Voisine, C., Rolland, T., Wachi, S., Soper, J.H., Zhu, Y., Orton, K.,
Villella, A., Garza, D., Vidal, M., et al. (2014). A chaperome subnetwork safe-
guards proteostasis in aging and neurodegenerative disease. Cell Rep. 9,
1135–1150.
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77,
71–94.
Calixto, A., Chelur, D., Topalidou, I., Chen, X., and Chalfie, M. (2010).
Enhanced neuronal RNAi in C. elegans using SID-1. Nat. Methods 7, 554–559.
Casanueva, M.O., Burga, A., and Lehner, B. (2012). Fitness trade-offs and
environmentally induced mutation buffering in isogenic C. elegans. Science
335, 82–85.
Chikka, M.R., Anbalagan, C., Dvorak, K., Dombeck, K., and Prahlad, V. (2016).
The mitochondria-regulated immune pathway activated in the C. elegans in-
testine is neuroprotective. Cell Rep. 16, 2399–2414.
Cohen, E., Paulsson, J.F., Blinder, P., Burstyn-Cohen, T., Du, D., Estepa, G.,
Adame, A., Pham, H.M., Holzenberger, M., Kelly, J.W., et al. (2009). Reduced
IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 139, 1157–
1169.
Douglas, P.M., Baird, N.A., Simic, M.S., Uhlein, S., McCormick, M.A., Wolff,
S.C., Kennedy, B.K., and Dillin, A. (2015). Heterotypic signals from neural
HSF-1 separate thermotolerance from longevity. Cell Rep. 12, 1196–1204.
Dowen, R.H., Breen, P.C., Tullius, T., Conery, A.L., and Ruvkun, G. (2016). A
microRNA program in the C. elegans hypodermis couples to intestinal
mTORC2/PQM-1 signaling to modulate fat transport. Genes Dev. 30, 1515–
1528.
Durieux, J., Wolff, S., and Dillin, A. (2011). The cell-non-autonomous nature of
electron transport chain-mediated longevity. Cell 144, 79–91.
Ermolaeva, M.A., Segref, A., Dakhovnik, A., Ou, H.-L., Schneider, J.I., Ute-
rmo¨hlen, O., Hoppe, T., and Schumacher, B. (2013). DNA damage in germ
cells induces an innate immune response that triggers systemic stress resis-
tance. Nature 501, 416–420.
Evans, C.G., Wise´n, S., and Gestwicki, J.E. (2006). Heat shock proteins 70 and
90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J. Biol.
Chem. 281, 33182–33191.
Fonte, V., Kipp, D.R., Yerg, J., 3rd, Merin, D., Forrestal, M., Wagner, E., Rob-
erts, C.M., and Link, C.D. (2008). Suppression of in vivo b-amyloid peptide
toxicity by overexpression of the HSP-16.2 small chaperone protein. J. Biol.
Chem. 283, 784–791.
Gardner, B.M., Pincus, D., Gotthardt, K., Gallagher, C.M., and Walter, P.
(2013). Endoplasmic reticulum stress sensing in the unfolded protein
response. Cold Spring Harb. Perspect. Biol. 5, a013169.
Hajdu-Cronin, Y.M., Chen, W.J., and Sternberg, P.W. (2004). The L-type cyclin
CYL-1 and the heat-shock-factor HSF-1 are required for heat-shock-induced
protein expression in Caenorhabditis elegans. Genetics 168, 1937–1949.
Hsu, A.-L., Murphy, C.T., and Kenyon, C. (2003). Regulation of aging and age-
related disease by DAF-16 and heat-shock factor. Science 300, 1142–1145.
Link, C.D. (1995). Expression of human beta-amyloid peptide in transgenic
Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 92, 9368–9372.
Mahadevan, N.R., Rodvold, J., Sepulveda, H., Rossi, S., Drew, A.F., and
Zanetti, M. (2011). Transmission of endoplasmic reticulum stress and pro-
inflammation from tumor cells to myeloid cells. Proc. Natl. Acad. Sci. USA
108, 6561–6566.
McColl, G., Roberts, B.R., Pukala, T.L., Kenche, V.B., Roberts, C.M., Link,
C.D., Ryan, T.M., Masters, C.L., Barnham, K.J., Bush, A.I., and Cherny, R.A.
(2012). Utility of an improved model of amyloid-beta (Ab142) toxicity in
Caenorhabditis elegans for drug screening for Alzheimer’s disease. Mol. Neu-
rodegener. 7, 57.
Mendenhall, A.R., Tedesco, P.M., Sands, B., Johnson, T.E., and Brent, R.
(2015). Single cell quantification of reporter gene expression in live adult Cae-
norhabditis elegans reveals reproducible cell-specific expression patterns and
underlying biological variation. PLoS ONE 10, e0124289.
Morimoto, R.I., Kline, M.P., Bimston, D.N., and Cotto, J.J. (1997). The heat-
shock response: regulation and function of heat-shock proteins andmolecular
chaperones. Essays Biochem. 32, 17–29.
Morley, J.F., Brignull, H.R., Weyers, J.J., and Morimoto, R.I. (2002). The
threshold for polyglutamine-expansion protein aggregation and cellular
toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc.
Natl. Acad. Sci. USA 99, 10417–10422.
Niu, W., Lu, Z.J., Zhong, M., Sarov, M., Murray, J.I., Brdlik, C.M., Janette, J.,
Chen, C., Alves, P., Preston, E., et al. (2011). Diverse transcription factor bind-
ing features revealed by genome-wide ChIP-seq in C. elegans. Genome Res.
21, 245–254.
Ostapchenko, V.G., Beraldo, F.H., Mohammad, A.H., Xie, Y.-F., Hirata, P.H.F.,
Magalhaes, A.C., Lamour, G., Li, H., Maciejewski, A., Belrose, J.C., et al.
(2013). The prion protein ligand, stress-inducible phosphoprotein 1, regulates
amyloid-b oligomer toxicity. J. Neurosci. 33, 16552–16564.
Owusu-Ansah, E., Song, W., and Perrimon, N. (2013). Muscle mitohormesis
promotes longevity via systemic repression of insulin signaling. Cell 155,
699–712.
Prahlad, V., and Morimoto, R.I. (2011). Neuronal circuitry regulates the
response of Caenorhabditis elegans to misfolded proteins. Proc. Natl. Acad.
Sci. USA 108, 14204–14209.
Prahlad, V., Cornelius, T., and Morimoto, R. (2008). Regulation of the cellular
heat shock response in Caenorhabditis elegans by thermosensory neurons.
Science 70, 811–814.
Reece-Hoyes, J.S., Shingles, J., Dupuy, D., Grove, C.A., Walhout, A.J.M., Vi-
dal, M., and Hope, I.A. (2007). Insight into transcription factor gene duplication
from Caenorhabditis elegans Promoterome-driven expression patterns. BMC
Genomics 8, 27.
Rongo, C., Whitfield, C.W., Rodal, A., Kim, S.K., and Kaplan, J.M. (1998).
LIN-10 is a shared component of the polarized protein localization pathways
in neurons and epithelia. Cell 94, 751–759.
Shapira, M., Hamlin, B.J., Rong, J., Chen, K., Ronen, M., and Tan, M.-W.
(2006). A conserved role for a GATA transcription factor in regulating epithelial
innate immune responses. Proc. Natl. Acad. Sci. USA 103, 14086–14091.Spencer, W.C., Zeller, G., Watson, J.D., Henz, S.R., Watkins, K.L., McWhirter,
R.D., Petersen, S., Sreedharan, V.T., Widmer, C., Jo, J., et al. (2011). A spatial
and temporal map of C. elegans gene expression. Genome Res. 21, 325–341.
Sun, J., Liu, Y., and Aballay, A. (2012). Organismal regulation of XBP-1-medi-
ated unfolded protein response during development and immune activation.
EMBO Rep. 13, 855–860.
Tatum, M.C., Ooi, F.K., Chikka, M.R., Chauve, L., Martinez-Velazquez, L.A.,
Steinbusch, H.W.M., Morimoto, R.I., and Prahlad, V. (2015b). Neuronal seroto-
nin release triggers the heat shock response in C. elegans in the absence of
temperature increase. Curr. Biol. 25, 163–174.
Taylor, R.C., and Dillin, A. (2013). XBP-1 is a cell-nonautonomous regulator of
stress resistance and longevity. Cell 153, 1435–1447.
Taylor, R.C., Berendzen, K.M., and Dillin, A. (2014). Systemic stress signalling:
understanding the cell non-autonomous control of proteostasis. Nat. Rev. Mol.
Cell Biol. 15, 211–217.
Templeman, N.M., Luo, S., Kaletsky, R., Shi, C., Ashraf, J., Keyes, W., and
Murphy, C.T. (2018). Insulin signaling regulates oocyte quality maintenance
with age via cathepsin B activity. Curr. Biol. 28, 753–760.e4.
Tepper, R.G., Ashraf, J., Kaletsky, R., Kleemann, G., Murphy, C.T., and Busse-
maker, H.J. (2013). PQM-1 complements DAF-16 as a key transcriptional
regulator of DAF-2-mediated development and longevity. Cell 154, 676–690.
van Oosten-Hawle, P., and Morimoto, R.I. (2014). Organismal proteostasis:
role of cell-nonautonomous regulation and transcellular chaperone signaling.
Genes Dev. 28, 1533–1543.
van Oosten-Hawle, P., Porter, R.S., and Morimoto, R.I. (2013). Regulation of
organismal proteostasis by transcellular chaperone signaling. Cell 153,
1366–1378.
Volovik, Y., Moll, L., Marques, F.C., Maman, M., Bejerano-Sagie, M., and Co-
hen, E. (2014). Differential regulation of the heat shock factor 1 and DAF-16 by
neuronal nhl-1 in the nematode C. elegans. Cell Rep. 9, 2192–2205.
Williams, K.W., Liu, T., Kong, X., Fukuda, M., Deng, Y., Berglund, E.D., Deng,
Z., Gao, Y., Liu, T., Sohn, J.-W., et al. (2014). Xbp1s in Pomc neurons connects
ER stress with energy balance and glucose homeostasis. Cell Metab. 20,
471–482.
Zheng, Y., Brockie, P.J., Mellem, J.E., Madsen, D.M., and Maricq, A.V. (1999).
Neuronal control of locomotion in C. elegans is modified by a dominant muta-
tion in the GLR-1 ionotropic glutamate receptor. Neuron 24, 347–361.
Zheng, Y., Brockie, P.J., Mellem, J.E., Madsen, D.M., Walker, C.S., Francis,
M.M., and Maricq, A.V. (2006). SOL-1 is an auxiliary subunit that modulates
the gating of GLR-1 glutamate receptors in Caenorhabditis elegans. Proc.
Natl. Acad. Sci. USA 103, 1100–1105.Cell Reports 23, 3905–3919, June 26, 2018 3919
